172 related articles for article (PubMed ID: 9073134)
1. Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis.
Sugano S; Suzuki T; Nishio M; Makino H; Okajima T
Dig Dis Sci; 1997 Mar; 42(3):529-35. PubMed ID: 9073134
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis.
Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
Hepatology; 1991 Jan; 13(1):124-8. PubMed ID: 1899080
[TBL] [Abstract][Full Text] [Related]
3. Relationship of portal pressure and colorectal vasculopathy in patients with cirrhosis.
Sugano S; Nishio M; Makino H; Suzuki T
Dig Dis Sci; 1999 Jan; 44(1):149-54. PubMed ID: 9952236
[TBL] [Abstract][Full Text] [Related]
4. Chronic splanchnic hemodynamic effects of spironolactone with unrestricted sodium diet in patients with compensated cirrhosis.
Sugano S; Kawafune T; Okajima T; Ishii K; Watanabe M; Takamura N
Dig Dis Sci; 1998 Apr; 43(4):893-7. PubMed ID: 9558049
[TBL] [Abstract][Full Text] [Related]
5. Transdermal nitroglycerin in cirrhosis. A 24-hour echo-Doppler study of splanchnic hemodynamics.
Zoli M; Magalotti D; Ghigi G; Marchesini G; Pisi E
J Hepatol; 1996 Oct; 25(4):498-503. PubMed ID: 8912149
[TBL] [Abstract][Full Text] [Related]
6. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T
Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
[TBL] [Abstract][Full Text] [Related]
7. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
[TBL] [Abstract][Full Text] [Related]
8. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
[TBL] [Abstract][Full Text] [Related]
9. Plasma volume contraction in portal hypertension.
Katsuta Y; Aramaki T; Sekiyama T; Satomura K; Okumura H; Okumura K [corrected to Okumura H]
J Hepatol; 1993; 17 Suppl 2():S19-23. PubMed ID: 8491966
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
Castaño G; Viudez P; Riccitelli M; Sookoian S
Ann Hepatol; 2003; 2(1):36-40. PubMed ID: 15094704
[TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis.
Clemmesen JO; Giraldi A; Ott P; Dalhoff K; Hansen BA; Larsen FS
World J Gastroenterol; 2008 Oct; 14(40):6208-12. PubMed ID: 18985812
[TBL] [Abstract][Full Text] [Related]
13. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Bosch J
P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effect of spironolactone in liver cirrhosis and propranolol-resistant portal hypertension.
Sen S; De BK; Biswas PK; Biswas J; Das D; Maity AK
Indian J Gastroenterol; 2002; 21(4):145-8. PubMed ID: 12385542
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
16. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
[TBL] [Abstract][Full Text] [Related]
18. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K
Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis.
García-Pagán JC; Salmerón JM; Feu F; Luca A; Ginés P; Pizcueta P; Claria J; Piera C; Arroyo V; Bosch J
Hepatology; 1994 May; 19(5):1095-9. PubMed ID: 8175131
[TBL] [Abstract][Full Text] [Related]
20. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
Li S
Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
